New Drug for Sleep Apnea

SOURCE nypost.com
A new drug called AD109 aims to treat sleep apnea and potentially replace CPAP machines, offering hope to sufferers of the disorder.

Key Points

  • AD109 drug is a combination of aroxybutynin and atomoxetine
  • Phase II trials show no major side effects
  • Third trial of the drug is ongoing
  • Lifestyle changes like weight loss and diet modifications can also help manage sleep apnea

Pros

  • AD109 drug shows promising results in treating sleep apnea
  • Potential alternative to cumbersome CPAP machines

Cons

  • Effectiveness may vary based on the severity of symptoms
  • Lack of oxygen saturation data in trial study raises concerns about long-term efficacy